Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resource requirements to accelerate clinical applications of next-generation sequencing and radiomics: workshop commentary and review.
Harris L, Shankar LK, Hildebrandt C, Rubinstein WS, Langlais K, Rodriguez H, Berger A, Freymann J, Huang EP, Williams PM, Zenklusen JC, Ochs R, Tezak Z, Sahiner B. Harris L, et al. Among authors: freymann j. J Natl Cancer Inst. 2024 Oct 1;116(10):1562-1570. doi: 10.1093/jnci/djae136. J Natl Cancer Inst. 2024. PMID: 38867688 Review.
Deep learning-based segmentation of multisite disease in ovarian cancer.
Buddenkotte T, Rundo L, Woitek R, Escudero Sanchez L, Beer L, Crispin-Ortuzar M, Etmann C, Mukherjee S, Bura V, McCague C, Sahin H, Pintican R, Zerunian M, Allajbeu I, Singh N, Sahdev A, Havrilesky L, Cohn DE, Bateman NW, Conrads TP, Darcy KM, Maxwell GL, Freymann JB, Öktem O, Brenton JD, Sala E, Schönlieb CB. Buddenkotte T, et al. Among authors: freymann jb. Eur Radiol Exp. 2023 Dec 7;7(1):77. doi: 10.1186/s41747-023-00388-z. Eur Radiol Exp. 2023. PMID: 38057616 Free PMC article.
The Brain Tumor Segmentation (BraTS) Challenge 2023: Brain MR Image Synthesis for Tumor Segmentation (BraSyn).
Li HB, Conte GM, Hu Q, Anwar SM, Kofler F, Ezhov I, van Leemput K, Piraud M, Diaz M, Cole B, Calabrese E, Rudie J, Meissen F, Adewole M, Janas A, Kazerooni AF, LaBella D, Moawad AW, Farahani K, Eddy J, Bergquist T, Chung V, Shinohara RT, Dako F, Wiggins W, Reitman Z, Wang C, Liu X, Jiang Z, Familiar A, Johanson E, Meier Z, Davatzikos C, Freymann J, Kirby J, Bilello M, Fathallah-Shaykh HM, Wiest R, Kirschke J, Colen RR, Kotrotsou A, Lamontagne P, Marcus D, Milchenko M, Nazeri A, Weber MA, Mahajan A, Mohan S, Mongan J, Hess C, Cha S, Villanueva-Meyer J, Colak E, Crivellaro P, Jakab A, Albrecht J, Anazodo U, Aboian M, Yu T, Chung V, Bergquist T, Eddy J, Albrecht J, Baid U, Bakas S, Linguraru MG, Menze B, Iglesias JE, Wiestler B. Li HB, et al. Among authors: freymann j. ArXiv [Preprint]. 2024 Nov 24:arXiv:2305.09011v6. ArXiv. 2024. PMID: 37608932 Free PMC article. Preprint.
Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Dou Y, Katsnelson L, Gritsenko MA, Hu Y, Reva B, Hong R, Wang YT, Kolodziejczak I, Lu RJ, Tsai CF, Bu W, Liu W, Guo X, An E, Arend RC, Bavarva J, Chen L, Chu RK, Czekański A, Davoli T, Demicco EG, DeLair D, Devereaux K, Dhanasekaran SM, Dottino P, Dover B, Fillmore TL, Foxall M, Hermann CE, Hiltke T, Hostetter G, Jędryka M, Jewell SD, Johnson I, Kahn AG, Ku AT, Kumar-Sinha C, Kurzawa P, Lazar AJ, Lazcano R, Lei JT, Li Y, Liao Y, Lih TM, Lin TT, Martignetti JA, Masand RP, Matkowski R, McKerrow W, Mesri M, Monroe ME, Moon J, Moore RJ, Nestor MD, Newton C, Omelchenko T, Omenn GS, Payne SH, Petyuk VA, Robles AI, Rodriguez H, Ruggles KV, Rykunov D, Savage SR, Schepmoes AA, Shi T, Shi Z, Tan J, Taylor M, Thiagarajan M, Wang JM, Weitz KK, Wen B, Williams CM, Wu Y, Wyczalkowski MA, Yi X, Zhang X, Zhao R, Mutch D, Chinnaiyan AM, Smith RD, Nesvizhskii AI, Wang P, Wiznerowicz M, Ding L, Mani DR, Zhang H, Anderson ML, Rodland KD, Zhang B, Liu T, Fenyö D; Clinical Proteomic Tumor Analysis Consortium. Dou Y, et al. Cancer Cell. 2023 Sep 11;41(9):1586-1605.e15. doi: 10.1016/j.ccell.2023.07.007. Epub 2023 Aug 10. Cancer Cell. 2023. PMID: 37567170 Free PMC article.
QU-BraTS: MICCAI BraTS 2020 Challenge on Quantifying Uncertainty in Brain Tumor Segmentation - Analysis of Ranking Scores and Benchmarking Results.
Mehta R, Filos A, Baid U, Sako C, McKinley R, Rebsamen M, Dätwyler K, Meier R, Radojewski P, Murugesan GK, Nalawade S, Ganesh C, Wagner B, Yu FF, Fei B, Madhuranthakam AJ, Maldjian JA, Daza L, Gómez C, Arbeláez P, Dai C, Wang S, Reynaud H, Mo Y, Angelini E, Guo Y, Bai W, Banerjee S, Pei L, Ak M, Rosas-González S, Zemmoura I, Tauber C, Vu MH, Nyholm T, Löfstedt T, Ballestar LM, Vilaplana V, McHugh H, Maso Talou G, Wang A, Patel J, Chang K, Hoebel K, Gidwani M, Arun N, Gupta S, Aggarwal M, Singh P, Gerstner ER, Kalpathy-Cramer J, Boutry N, Huard A, Vidyaratne L, Rahman MM, Iftekharuddin KM, Chazalon J, Puybareau E, Tochon G, Ma J, Cabezas M, Llado X, Oliver A, Valencia L, Valverde S, Amian M, Soltaninejad M, Myronenko A, Hatamizadeh A, Feng X, Dou Q, Tustison N, Meyer C, Shah NA, Talbar S, Weber MA, Mahajan A, Jakab A, Wiest R, Fathallah-Shaykh HM, Nazeri A, Milchenko M, Marcus D, Kotrotsou A, Colen R, Freymann J, Kirby J, Davatzikos C, Menze B, Bakas S, Gal Y, Arbel T. Mehta R, et al. Among authors: freymann j. J Mach Learn Biomed Imaging. 2022 Aug;2022:https://www.melba-journal.org/papers/2022:026.html. J Mach Learn Biomed Imaging. 2022. PMID: 36998700 Free PMC article.
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.
Li Y, Lih TM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, Wu Y, Lu RJ, Clark DJ, Kołodziejczak I, Hong R, Chen S, Zhao Y, Chugh S, Caravan W, Naser Al Deen N, Hosseini N, Newton CJ, Krug K, Xu Y, Cho KC, Hu Y, Zhang Y, Kumar-Sinha C, Ma W, Calinawan A, Wyczalkowski MA, Wendl MC, Wang Y, Guo S, Zhang C, Le A, Dagar A, Hopkins A, Cho H, Leprevost FDV, Jing X, Teo GC, Liu W, Reimers MA, Pachynski R, Lazar AJ, Chinnaiyan AM, Van Tine BA, Zhang B, Rodland KD, Getz G, Mani DR, Wang P, Chen F, Hostetter G, Thiagarajan M, Linehan WM, Fenyö D, Jewell SD, Omenn GS, Mehra R, Wiznerowicz M, Robles AI, Mesri M, Hiltke T, An E, Rodriguez H, Chan DW, Ricketts CJ, Nesvizhskii AI, Zhang H, Ding L; Clinical Proteomic Tumor Analysis Consortium. Li Y, et al. Cancer Cell. 2023 Jan 9;41(1):139-163.e17. doi: 10.1016/j.ccell.2022.12.001. Epub 2022 Dec 22. Cancer Cell. 2023. PMID: 36563681 Free PMC article.
Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis.
Beer L, Sahin H, Bateman NW, Blazic I, Vargas HA, Veeraraghavan H, Kirby J, Fevrier-Sullivan B, Freymann JB, Jaffe CC, Brenton J, Miccó M, Nougaret S, Darcy KM, Maxwell GL, Conrads TP, Huang E, Sala E. Beer L, et al. Among authors: freymann jb. Eur Radiol. 2020 Aug;30(8):4306-4316. doi: 10.1007/s00330-020-06755-3. Epub 2020 Apr 6. Eur Radiol. 2020. PMID: 32253542 Free PMC article.
80 results